These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 19490173)

  • 1. Persistently normal alanine aminotransferase levels in HIV/HCV-coinfected patients: the role of steatosis.
    Bani-Sadr F; Barange K; Daoud F; Jacomet C; Bicart-See A; Rosenthal E; Cacoub P; Pol S; Perronne C; Carrat F;
    HIV Med; 2009 Aug; 10(7):417-21. PubMed ID: 19490173
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Liver biopsy findings for HIV-infected patients with chronic hepatitis C and persistently normal levels of alanine aminotransferase.
    Sánchez-Conde M; Berenguer J; Miralles P; Alvarez F; Carlos Lopez J; Cosin J; Pilar C; Ramirez M; Gutierrez I; Alvarez E
    Clin Infect Dis; 2006 Sep; 43(5):640-4. PubMed ID: 16886160
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Liver fibrosis in patients with chronic hepatitis C and persistently normal liver enzymes: influence of HIV infection.
    Martin-Carbonero L; de Ledinghen V; Moreno A; Maida I; Foucher J; Barreiro P; Romero M; Satta G; Garcia-Samaniego J; Gonzalez-Lahoz J; Soriano V
    J Viral Hepat; 2009 Nov; 16(11):790-5. PubMed ID: 19413693
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatic steatosis in HIV-HCV coinfected patients: analysis of risk factors.
    Bani-Sadr F; Carrat F; Bedossa P; Piroth L; Cacoub P; Perronne C; Degott C; Pol S;
    AIDS; 2006 Feb; 20(4):525-31. PubMed ID: 16470116
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Histological findings and clinical characteristics associated with hepatic steatosis in patients coinfected with HIV and hepatitis C virus.
    Marks KM; Petrovic LM; Talal AH; Murray MP; Gulick RM; Glesby MJ
    J Infect Dis; 2005 Dec; 192(11):1943-9. PubMed ID: 16267765
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Is serum alanine transaminase level a reliable marker of histological disease in chronic hepatitis C infection?
    Sanai FM; Benmousa A; Al-Hussaini H; Ashraf S; Alhafi O; Abdo AA; Alameri HF; Akbar HO; Bzeizi KI
    Liver Int; 2008 Aug; 28(7):1011-8. PubMed ID: 18384520
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predictors of liver fibrosis in HIV-infected patients with chronic hepatitis C virus (HCV) infection: assessment using transient elastometry and the role of HCV genotype 3.
    Barreiro P; Martín-Carbonero L; Núñez M; Rivas P; Morente A; Simarro N; Labarga P; González-Lahoz J; Soriano V
    Clin Infect Dis; 2006 Apr; 42(7):1032-9. PubMed ID: 16511772
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical, histological, and virological features of hepatitis C virus carriers with persistently normal or abnormal alanine transaminase levels.
    Puoti C; Magrini A; Stati T; Rigato P; Montagnese F; Rossi P; Aldegheri L; Resta S
    Hepatology; 1997 Dec; 26(6):1393-8. PubMed ID: 9397976
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Incidence and risk factors for chronic elevation of alanine aminotransferase levels in HIV-infected persons without hepatitis b or c virus co-infection.
    Kovari H; Ledergerber B; Battegay M; Rauch A; Hirschel B; Foguena AK; Vernazza P; Bernasconi E; Mueller NJ; Weber R
    Clin Infect Dis; 2010 Feb; 50(4):502-11. PubMed ID: 20085465
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HIV coinfection and antiretroviral therapy enhances liver steatosis in patients with hepatitis C, but only in those infected by HCV genotype other than 3.
    Borghi V; Puoti M; Mussini C; Bellelli S; Angeletti C; Sabbatini F; Prati F; Cossarizza A; Esposito R
    Antivir Ther; 2008; 13(8):1057-65. PubMed ID: 19195331
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Significance of hepatitis C virus coinfection with persistently normal alanine aminotransferase levels in HIV-1-infected patients.
    Fonquernie L; Serfaty L; Charrois A; Wendum D; Lefebvre B; Girard PM; Meynard JL
    HIV Med; 2004 Sep; 5(5):385-90. PubMed ID: 15369515
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Slow progression rate of fibrosis in hepatitis C virus patients with persistently normal alanine transaminase activity.
    Mathurin P; Moussalli J; Cadranel JF; Thibault V; Charlotte F; Dumouchel P; Cazier A; Huraux JM; Devergie B; Vidaud M; Opolon P; Poynard T
    Hepatology; 1998 Mar; 27(3):868-72. PubMed ID: 9500720
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chronic hepatitis C in patients with persistently normal alanine transaminase levels.
    Shiffman ML; Diago M; Tran A; Pockros P; Reindollar R; Prati D; Rodríguez-Torres M; Lardelli P; Blotner S; Zeuzem S
    Clin Gastroenterol Hepatol; 2006 May; 4(5):645-52. PubMed ID: 16630770
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical features of hepatitis C-infected patients with persistently normal alanine transaminase levels in the Southwestern United States.
    Jamal MM; Soni A; Quinn PG; Wheeler DE; Arora S; Johnston DE
    Hepatology; 1999 Nov; 30(5):1307-11. PubMed ID: 10534355
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interferon monotherapy for patients with chronic hepatitis C and normal serum aminotransferase levels at commencement of treatment.
    Mamori S; Suzuki F; Hosaka T; Akuta N; Someya T; Kobayashi M; Tsubota A; Suzuki Y; Saitoh S; Arase Y; Ikeda K; Kumada H
    J Gastroenterol; 2004 Aug; 39(8):776-82. PubMed ID: 15338372
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Liver injury and changes in hepatitis C Virus (HCV) RNA load associated with protease inhibitor-based antiretroviral therapy for treatment-naive HCV-HIV-coinfected patients: lopinavir-ritonavir versus nelfinavir.
    Sherman KE; Shire NJ; Cernohous P; Rouster SD; Omachi JH; Brun S; Da Silva B
    Clin Infect Dis; 2005 Oct; 41(8):1186-95. PubMed ID: 16163639
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Documented rapid course of hepatic fibrosis between two biopsies in patients coinfected by HIV and HCV despite high CD4 cell count.
    Bonnard P; Lescure FX; Amiel C; Guiard-Schmid JB; Callard P; Gharakhanian S; Pialoux G
    J Viral Hepat; 2007 Nov; 14(11):806-11. PubMed ID: 17927617
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatitis C infection in Alaska Natives with persistently normal, persistently elevated or fluctuating alanine aminotransferase levels.
    Bruce MG; Bruden D; McMahon BJ; Christensen C; Homan C; Sullivan D; Deubner H; Hennessy T; Williams J; Livingston S; Gretch D
    Liver Int; 2006 Aug; 26(6):643-9. PubMed ID: 16842319
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chronic hepatitis C infection in patients with end stage renal disease: characterization of liver histology and viral load in patients awaiting renal transplantation.
    Sterling RK; Sanyal AJ; Luketic VA; Stravitz RT; King AL; Post AB; Mills AS; Contos MJ; Shiffman ML
    Am J Gastroenterol; 1999 Dec; 94(12):3576-82. PubMed ID: 10606322
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HIV and HCV co-infection: situation at six French university hospitals in the year 2000.
    Buffet-Janvresse C; Peigue-Lafeuille H; Benichou J; Vabret A; Branger M; Trimoulet P; Goria O; Laurichesse H; Abbed A; Verdon R; Bouvet E; Lafon ME; Dussaix E; Cormerais L; Dupon M; Henquell C; Josse A; Lagoutte P; Lariven S; LeGac S; Riachi G; Verdon R; Vittecoq D;
    J Med Virol; 2003 Jan; 69(1):7-17. PubMed ID: 12436472
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.